Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Trial Evaluating Bevacizumabe or Triamcinolone for Persistent Diabetic Macular Edema

NCT02985619 is registered in ClinicalTrials.gov with University of Sao Paulo as lead sponsor.

NCT NCT02985619
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02985619 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Trial Evaluating Bevacizumabe or Triamcinolone for Persistent Diabetic Macular Edema
Lead sponsor
University of Sao Paulo
Phase
Phase 2/3
Overall status
Completed
Start date
July 21, 2016
Completion date
December 21, 2017
Enrollment
100 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema